Selection of Nicotine Therapy to Increase Quitting
- Conditions
- Smoking (healthy participants who smoke)Mental Health - Addiction
- Registration Number
- ACTRN12606000451505
- Lead Sponsor
- Clinical Trials Research Unit, School of Population Health, Auckland University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1100
Participants will be people from throughout New Zealand who smoke, who contact Quitline (by phone) for smoking cessation advice and assistance. Smokers will be eligible provided they: want to stop smoking within the next two weeks; have their first cigarette within 30 minutes of waking; are able to provide verbal consent; have a telephone.
Pregnant women and women who are breastfeeding will be excluded from the trial. People will also be excluded from the trial if they meet any of the following criteria: current users of NRT products; current users of Zyban (buproprion), clonidine or nortriptyline; use only non-cigarette tobacco products (e.g. pipes, cigars); have had a myocardial infarction within the last three months; and have had unstable or progressive angina pectoris, Prinzmetal’s angina, severe cardiac arrhythmia or a stroke in acute phase.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of participants who report 7-day point prevalence abstinence[At six months after Quit day (biochemically verified)]
- Secondary Outcome Measures
Name Time Method